
Aerie Pharmaceuticals AERI
Quartalsbericht 2022-Q3
hinzugefügt 23.12.2023
Aerie Pharmaceuticals Allgemeine Reserven 2011-2026 | AERI
Allgemeine Reserven Jährlich Aerie Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 40.4 M | 27.1 M | 21.1 M | 10.1 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.4 M | 10.1 M | 24.7 M |
Allgemeine Reserven Vierteljährlich Aerie Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 46.8 M | 47 M | 40.2 M | 40.4 M | 30.1 M | 30.7 M | 28.3 M | 27.1 M | 20.8 M | 19.1 M | 20.2 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 47 M | 10.1 M | 25 M |
Allgemeine Reserven anderer Aktien in der Arzneimittelhersteller
| Name | Allgemeine Reserven | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | ||
|
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.19 | 0.85 % | $ 128 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M | ||
|
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | ||
|
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
482 K | - | - | $ 36.6 M | ||
|
Emergent BioSolutions
EBS
|
329 M | $ 13.9 | 5.7 % | $ 712 M | ||
|
Pacira BioSciences
PCRX
|
125 M | $ 26.0 | 2.73 % | $ 1.2 B | ||
|
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | $ 21.5 | - | $ 2.05 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 3.74 | -1.58 % | $ 4.64 M | ||
|
Evolus
EOLS
|
12.2 M | $ 5.66 | -4.23 % | $ 351 M | ||
|
Harrow Health
HROW
|
10.9 M | $ 51.0 | -4.67 % | $ 1.66 B | ||
|
China Pharma Holdings
CPHI
|
2.27 M | $ 1.35 | 5.88 % | $ 23.6 M | ||
|
Jupiter Wellness
JUPW
|
234 K | - | - | $ 33.6 M | ||
|
Bausch Health Companies
BHC
|
1.54 B | $ 7.9 | 3.47 % | $ 2.88 B | ||
|
Veru
VERU
|
4.14 M | $ 2.37 | 1.72 % | $ 320 M | ||
|
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | ||
|
cbdMD
YCBD
|
2.52 M | $ 1.1 | -4.35 % | $ 4.74 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 5.19 | 9.96 % | $ 73 M | ||
|
Organogenesis Holdings
ORGO
|
26.2 M | $ 4.3 | -1.38 % | $ 566 M | ||
|
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | ||
|
Perrigo Company plc
PRGO
|
1.08 B | $ 14.59 | -1.19 % | $ 2 B | ||
|
ProPhase Labs
PRPH
|
3.98 M | - | - | $ 5.07 M | ||
|
Rockwell Medical
RMTI
|
5.87 M | $ 0.95 | 2.78 % | $ 22.2 M | ||
|
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | ||
|
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
37.7 M | $ 9.43 | -1.05 % | $ 670 M | ||
|
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
899 K | $ 0.64 | -0.05 % | $ 30.6 M | ||
|
Tilray
TLRY
|
201 M | $ 8.99 | -2.92 % | $ 5.56 B | ||
|
TherapeuticsMD
TXMD
|
7.99 M | $ 2.04 | - | $ 21.3 M | ||
|
Viatris
VTRS
|
3.52 B | $ 12.46 | 0.48 % | $ 15.1 B | ||
|
Zomedica Corp.
ZOM
|
5.12 M | - | -0.21 % | $ 98 M |